secwatch.observer — SEC 8-K summary
======================================

Issuer:     Propanc Biopharma, Inc. (PPCB)
CIK:        0001517681
Form:       8-K
Filed at:   2024-04-22T23:59:59+00:00
Accession:  0001493152-24-015494
Event type: debt
Sentiment:  neutral
Materiality: 0.30
Item codes: 1.01, 2.03, 3.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Propanc Biopharma issues $27,500 convertible note to GS Capital Partners
------------------------------------------------------------------------

- Entered into securities purchase agreement; note principal $27,500 at $25,000 purchase price (original issue discount).
- Note bears 8% interest (24% on default), matures October 12, 2024; conversion price initially $0.0017/share.
- Conversion price adjusts to $0.001 if stock trades below $0.0014 for 5 consecutive days; default triggers alternate fixed price.
- Company may prepay at 110-125% within 180 days; after 180 days no prepayment right.
- Note issued under Regulation D private placement; proceeds for general working capital.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224015494/0001493152-24-015494-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1517681/000149315224015494/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-015494

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer